Streetbeat News

INCR

InterCure Ltd.

https://www.intercure.co

Industry

Drug Manufacturers - Specialty & Generic

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

InterCure Ltd. (NASDAQ:INCR), a leading medical cannabis company in Israel, has provided an update on the security situation in Israel and its impact on the company and its employees. The company's main facility is located in Kibbutz Nir Oz, near the Gaza border, which has been affected by recent attacks from Hamas terrorists. Despite the challenges, the company's management, cannabis trading houses, and pharmacies are working diligently to meet the growing demand for the company's products.

Portfolio Pulse from Charles Gross

October 17, 2023 | 9:07 pm

InterCure Ltd. (NASDAQ:INCR), doing business as Canndoc, reported a 14% YoY revenue growth for 1H 2023, totaling CA$75 million ($55.4 million). However, operating profit and adjusted EBITDA were down compared to the same period in 2022. The company is optimistic about new cannabis regulations in Israel and Germany and potential opportunities in the U.S. following a reclassification of cannabis by the DEA. InterCure's shares traded 1.86% higher in the pre-market session on Friday.

Portfolio Pulse from Jelena Martinovic

September 01, 2023 | 1:48 pm

Intercure (NASDAQ:INCR) reported a decrease in quarterly earnings from $0.17 per share last year to $0.03 per share this year, a drop of 82.35%. However, the company's sales increased by 14.29% from $50.05 million to $57.20 million over the same period.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 5:46 am

The article lists the cannabis stocks that gained and lost on August 24, 2023. Notable gainers include EVIO, Red White & Bloom Brands, and CBD Unlimited. Major losers include Choom Holdings, Radient Technologies, and Target Group.

Portfolio Pulse from Benzinga Insights

August 24, 2023 | 9:30 pm

The cannabis sector experienced mixed performance on August 21, 2023, with several stocks seeing significant gains, while others suffered losses. Notable gainers include Radient Technologies (OTC:RDDTF), Trees (OTC:CANN), and 1933 Industries (OTC:TGIFF), while Red White & Bloom Brands (OTC:RWBYF), CBD Of Denver (OTC:CBDD), and Tetra Bio Pharma (OTC:TBPMF) were among the biggest losers.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 9:30 pm

On August 18, 2023, several cannabis stocks experienced significant price movements. Notable gainers include Australis Capital (OTC:AUSAF), Target Group (OTC:CBDY), and 1606 (OTC:CBDW), with shares closing up 900.00%, 63.64%, and 44.68% respectively. On the other hand, Panacea Life Sciences (OTC:PLSH), MGC Pharmaceuticals (OTC:MGCLF), and 1933 Industries (OTC:TGIFF) were among the biggest losers, with shares closing down 24.00%, 23.33%, and 19.00% respectively.

Portfolio Pulse from Benzinga Insights

August 18, 2023 | 9:30 pm

The article lists the cannabis stocks that gained and lost on August 14, 2023. Some of the biggest gainers include Choom Holdings, Zynerba Pharmaceuticals, and Maple Leaf Green World. On the other hand, Red White & Bloom Brands, GrowLife, and Tetra Bio Pharma were among the biggest losers.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 9:30 pm

During Friday's session, 157 stocks hit new 52-week lows. Among the notable companies were Corteva, American Rebel Holdings, Mullen Automotive, and BNY Mellon Strategic. The stocks that created new 52-week lows on Friday included Avangrid, SolarEdge Technologies, Etsy, UGI, Concentrix, Hawaiian Electric Indus, Equity Commonwealth, Forward Air, Cracker Barrel Old, Petco Health and Wellness, JinkoSolar Holding Co, Olaplex Hldgs, Frontier Group Holdings, Impinj, Safehold, Monro, 3D Sys, TDCX, Everbridge, Silk Road Medical, Cassava Sciences, 23andMe Holding, Wolverine World Wide, Avidity Biosciences, Boston Omaha, John Hancock Premium Div, BioLife Solns, Seres Therapeutics, American Well, Materialise, BNY Mellon Strategic, Southland Holdings, Funko, Fate Therapeutics, Citizens Financial Servs, American Lithium, Emergent BioSolutions, PetMed Express, Sutro Biopharma, Hippo Holdings, Largo, Omega Therapeutics, System1, Benson Hill, Eaton Vance Municipal, Vor Biopharma, Star Hldgs, Origin Mat, Joint, NanoString Technologies, Codexis, ContextLogic, Akoustis Technologies, Cano Health, GeneDx Hldgs, Electrovaya, Kezar Life Sciences, ProPhase Labs, Alaunos Therapeutics, Chimerix, Electriq Power Holdings, DZS, Streamline Health Solns, Eargo, Intercure, Prime Number Acquisition, REE Automotive, TD Hldgs, Carmell Therapeutics, Neuronetics, Kaixin Auto Hldgs, Crown Crafts, Airgain, Ohmyhome, Singular Genomics Sys, First Seacoast Bancorp, Sarcos Technology, Coya Therapeutics, Otonomo Technologies, CareCloud, Aterian, PAVmed, Orgenesis, CalAmp, Imperial Ptrl, Fitell, LQR House, Iridex, OMNIQ, Safeguard Scientifics, Lichen China, Origin Agritech, Atreca, Sunlight Finl Hldgs, Yunji, MediaCo Holding, Trio Petroleum, Cineverse, Lucy Scientific Discovery, Remark Hldgs, Shuttle Pharmaceuticals, Hempacco, Finch Therapeutics Gr, Visionary Education Tech, Marpai, Ontrak, Nogin, Adamis Pharmaceuticals, China Jo-Jo Drugstores, ABVC BioPharma, Fangdd Network Group, SeaStar Medical Holding, Yoshiharu Global, Universe Pharmaceuticals, Redhill Biopharma, Jiuzi Hldgs, Power REIT, Soligenix, Eightco Holdings, JanOne, Avalo Therapeutics, Yield10 Bioscience, Aditxt, Salarius Pharmaceuticals, China Pharma Holding, OpGen, Akanda, Harbor Custom Dev, Biocept, NeuBase Therapeutics, Ucommune International, INVO Bioscience, Esports Entertainment, American Rebel Holdings.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:01 pm

The article lists the cannabis stocks that gained and lost on August 10, 2023. The biggest gainers were Choom Holdings (OTC:CHOOF), Item 9 Labs (OTC:INLB), and Delivra Health Brands (OTC:DHBUF), while the biggest losers were CannTrust Holdings (OTC:CNTTQ), SciSparc (NASDAQ:SPRC), and Khiron Life Sciences (OTC:KHRNF).

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 9:30 pm

The article lists the marijuana stocks that gained and lost on August 9, 2023. Notable gainers include CannTrust Holdings (OTC:CNTTQ), Humble & Fume (OTC:HUMBF), and Maple Leaf Green World (OTC:MGWFF). Significant losers include Gaby (OTC:GABLF), Rocky Mountain High (OTC:RMHB), and GrowGeneration (NASDAQ:GRWG).

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.